{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "82868-040",
      "generic_name": "ORPHENADRINE CITRATE",
      "labeler_name": "Northwind Health Company, LLC",
      "brand_name": "ORPHENADRINE CITRATE",
      "active_ingredients": [
        {
          "name": "ORPHENADRINE CITRATE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "82868-040-14",
          "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-040-14)",
          "marketing_start_date": "20240130",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Northwind Health Company, LLC"
        ],
        "rxcui": [
          "994521"
        ],
        "spl_set_id": [
          "106be130-b4f8-5ca1-e063-6294a90a1590"
        ],
        "unii": [
          "X0A40N8I4S"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "47f8f308-ca39-d280-e063-6394a90a49e9",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240130",
      "product_id": "82868-040_47f8f308-ca39-d280-e063-6394a90a49e9",
      "application_number": "ANDA040284",
      "brand_name_base": "ORPHENADRINE CITRATE",
      "pharm_class": [
        "Centrally-mediated Muscle Relaxation [PE]",
        "Muscle Relaxant [EPC]"
      ]
    }
  ]
}